Replies to post #3820 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

[OT]—

…bought back their shares from Genzyme, and then sold multiples of those shares on subsequent lower and lower and lower priced financings.

The buyback you refer to was part of a larger transaction that resulted in an independent company being created from a former subsidiary of GENZ; hence, that transaction was an altogether different animal from the MNTA buyback proposed by Palo Alto.

I don't recall your objections to that malfeasance, dd.

I wasn’t a shareholder when the buyback in question occurred.